Literature DB >> 4083048

Endothelial negative surface charge areas and blood-brain barrier function.

J E Hardebo, J Kåhrström.   

Abstract

Recent evidence points to the negative surface charge of the luminal endothelial membrane of brain vessels as one determinant for morphologic blood-brain barrier function. The present study evaluates, in awake rats, how barrier function is affected by the polycation protamine to neutralize the negatively charged groups. High local doses of protamine, as infused intracarotideally, are able to substantially impair barrier capacity against albumin and inulin, which normally do not pass the blood-brain barrier. Evidence is presented that it is the positive charge of protamine that is a major factor underlying the barrier opening. However, when comparing the barrier opening obtained by corresponding concentration of the polycation lysine, it was obvious that another property of protamine contributed. This property was not linked to hyperosmolar, hypertensive or vasodilatory barrier opening, but may be a direct, cytotoxic effect of protamine. It is discussed whether barrier opening through transendothelial vesicular or channel transport occurs only at locations on the cell membrane deprived of negative surface charge areas.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4083048     DOI: 10.1111/j.1748-1716.1985.tb07746.x

Source DB:  PubMed          Journal:  Acta Physiol Scand        ISSN: 0001-6772


  24 in total

Review 1.  Peptide delivery to the brain via adsorptive-mediated endocytosis: advances with SynB vectors.

Authors:  Guillaume Drin; Christophe Rousselle; Jean-Michel Scherrmann; Anthony R Rees; Jamal Temsamani
Journal:  AAPS PharmSci       Date:  2002

Review 2.  Xenobiotic pulmonary exposure and systemic cardiovascular response via neurological links.

Authors:  Phoebe A Stapleton; Alaeddin B Abukabda; Steven L Hardy; Timothy R Nurkiewicz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-09-18       Impact factor: 4.733

Review 3.  From blood-brain barrier to blood-brain interface: new opportunities for CNS drug delivery.

Authors:  William A Banks
Journal:  Nat Rev Drug Discov       Date:  2016-01-22       Impact factor: 84.694

Review 4.  In vitro methods in the study of viral and prion permeability across the blood-brain barrier.

Authors:  Ryota Nakaoke; William A Banks
Journal:  Cell Mol Neurobiol       Date:  2005-02       Impact factor: 5.046

Review 5.  CNS drug delivery: opioid peptides and the blood-brain barrier.

Authors:  Ken A Witt; Thomas P Davis
Journal:  AAPS J       Date:  2006-02-24       Impact factor: 4.009

6.  Vascular Pathology as a Potential Therapeutic Target in SCI.

Authors:  Richard L Benton; Theo Hagg
Journal:  Transl Stroke Res       Date:  2011-11-29       Impact factor: 6.829

7.  A unique heparin-binding domain in the envelope protein of the neuropathogenic PVC-211 murine leukemia virus may contribute to its brain capillary endothelial cell tropism.

Authors:  A Jinno-Oue; M Oue; S K Ruscetti
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

Review 8.  Agile delivery of protein therapeutics to CNS.

Authors:  Xiang Yi; Devika S Manickam; Anna Brynskikh; Alexander V Kabanov
Journal:  J Control Release       Date:  2014-06-21       Impact factor: 9.776

Review 9.  Nanotechnology: toxicologic pathology.

Authors:  Ann F Hubbs; Linda M Sargent; Dale W Porter; Tina M Sager; Bean T Chen; David G Frazer; Vincent Castranova; Krishnan Sriram; Timothy R Nurkiewicz; Steven H Reynolds; Lori A Battelli; Diane Schwegler-Berry; Walter McKinney; Kara L Fluharty; Robert R Mercer
Journal:  Toxicol Pathol       Date:  2013-02-06       Impact factor: 1.902

10.  Physiologic upper limit of pore size in the blood-tumor barrier of malignant solid tumors.

Authors:  Hemant Sarin; Ariel S Kanevsky; Haitao Wu; Alioscka A Sousa; Colin M Wilson; Maria A Aronova; Gary L Griffiths; Richard D Leapman; Howard Q Vo
Journal:  J Transl Med       Date:  2009-06-23       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.